Brief: Eli Lilly Close To Buying Gene-Editing Biotech Verve Therapeutics - FT
June 16 (Reuters) - ELI LILLY CLOSE TO BUYING GENE-EDITING BIOTECH VERVE THERAPEUTICS- FT ELI LILLY IS IN ADVANCED TALKS TO BUY GENE EDITING START-UP VERVE THERAPEUTICS FOR UP TO $1.3BN - FT Source text: https://on.ft.com/4e57goZ Further company coverage: LLY.N ((Reuters.Briefs@thomsonreuters.com;;))